Delivery Order 75N93023D00001-75N93026F00001
Award Date 8/1/26
Potential Completion Date 7/31/27
Potential Value $2.7M
Federal Agency
Ultimate Awardee
Not listed NAICS Category
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Cost Plus Fixed Fee
Place of Performance
Rockville, MD 20850, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
1
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a cost-plus-fixed-fee delivery order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to Advanced Bioscience Laboratories, Inc. (ABL) to use artificial intelligence/machine learning (AI/ML) to enhance the STEP pediatric excipient database. The contract, valued at $1,193,090.00, has a period of performance through September 30, 2025. It is not a set-aside contract. The contract is part of a larger $98.9 million Indefinite Delivery...
- The National Institute of Allergy and Infectious Diseases issued a delivery order to Advanced Bioscience Laboratories, Inc. on September 1, 2019, with a ceiling value of $1,261,199.23 under the HIV Microbicides and Biomedical Prevention 2016–2021 parent IDIQ for statistical and pharmacometric modeling support for HIV nonvaccine biomedical prevention product development. Place of performance is Rockville, MD. The order is priced on a cost-plus-fixed-fee basis and completed on August 31, 2023....
- The National Institute of Allergy and Infectious Diseases issued a delivery order to Advanced Bioscience Laboratories, Inc., valued at $537,740.10, on August 9, 2018, under the HIV Microbicides and Biomedical Prevention 2016–2021 IDIQ for ethnographic research related to enhancement of study drug adherence and uptake in HIV prevention trials. Place of performance is Rockville, MD. The order is priced on a cost-plus-fixed-fee basis with a ceiling value of $537,740.10 and ultimate completion...
- The National Institute of Allergy and Infectious Diseases issued a delivery order to Advanced Bioscience Laboratories, Inc. on July 15, 2023, with a ceiling value of $483,682, under the Resources to Advance Pediatrics and HIV Prevention Science IDIQ for material and data receipt, storage, shipping, and inventory services. Place of performance is Rockville, MD. The order runs through July 14, 2030, under cost-plus-fixed-fee pricing with no set-aside designation. Service Contract Inventory data...
- The National Institute of Allergy and Infectious Diseases issued a delivery order to Advanced Bioscience Laboratories, Inc. on November 30, 2016, under the HIV Microbicides and Biomedical Prevention 2016–2021 IDIQ, with a ceiling value of $530,845.56 for material receipt, storage, shipping, and inventory services. Place of performance is Rockville, Maryland. The order was priced on a cost-plus-fixed-fee basis with an ultimate completion date of July 14, 2023. No set-aside was used.
- The National Institute of Allergy and Infectious Diseases issued a delivery order to Advanced Bioscience Laboratories, Inc. on June 29, 2017, with a ceiling value of $8,677,861.82 for nonhuman primate purchase and holding under the HIV Microbicides and Biomedical Prevention 2016-2021 IDIQ. The order is priced on a cost-plus-fixed-fee basis with place of performance in Rockville, MD and an ultimate completion date of June 30, 2024. The parent IDIQ supports preclinical development services for...
- The National Institute of Allergy and Infectious Diseases issued a delivery order to Advanced Bioscience Laboratories, Inc., with a ceiling value of $79,489.53, on July 1, 2019, under the HIV Microbicides and Biomedical Prevention 2016-2021 IDIQ. The order required ABL to assist NIAID in planning and implementing two separate consultations for NIAID contractors and extramural programmatic staff addressing quality management systems and quality risk management. Place of performance is...
- <p>The National Institute of Allergy and Infectious Diseases issued a delivery order to Advanced Bioscience Laboratories, Inc. on May 2, 2014, for NIAID preclinical development support — SVEU database rewrite, with a ceiling value of $526,079.33.</p> <p>The order is priced on a cost-plus-fixed-fee basis. Place of performance is Rockville, MD. The ultimate completion date is April 30, 2016. No set-aside was used for this delivery order.</p>
- <p>The National Institute of Allergy and Infectious Diseases issued a delivery order to Advanced Bioscience Laboratories, Inc. on September 25, 2014, with a ceiling value of $494,513.97, for preclinical development support including expression and production of HIV-1 envelope protein.</p> <p>Place of performance is Rockville, MD. The delivery order is priced on a cost-plus-fixed-fee basis with an ultimate completion date of September 25, 2017. No set-aside was used.</p>
- This task order funds the guaranteed minimum amount under a preexisting master indefinite-delivery/indefinite-quantity contract between the National Institutes of Health's National Institute of Allergy and Infectious Diseases and Advanced Bioscience Laboratories, Inc. The purpose is to support preclinical and translational vaccine development for HIV and other candidate agents. The $2,500 delivery order was awarded on December 1, 2021 with a one-year period of performance ending November 30,...